Free Press Release

FaceBook Page Twitter Feed
You are here: Home > Exclusive News > Health Point Inc. Revolutionary Stem Cell Trials Promotes Vasculogenesis

Health Point Inc. Revolutionary Stem Cell Trials Promotes Vasculogenesis

Posted Nov 21, 2014 by reginaldanderson
Experimental stem cell techniques developed by Health Point Inc. are showing significant progress in stimulating new vein growth in damaged tissue, a process known as vasculogenesis.

FOR IMMEDIATE RELEASE (Press Release) Nov 21, 2014 -- The principle behind this treatment is based on the stem cells ability to generate new vascular pathways. In most cases stem cell transplantation is performed locally, however if the condition indicate against surgery, larger doses of hematopoietic and mesenchymal progenitor cells may be applied.

In the study of advancing treatment of chronic lower limb ischemia, there is evidence of hematopoietic and mesenchymal progenitor cells creating new capillaries. Health Point Inc. anticipates a further expansion of research facilities to further the understanding of this breakthrough process.

Health Point Inc. (HPI) is a privately-owned company specializing in the development, manufacture and supply of stem cells for basic research and therapeutic development for the treatment of various diseases and conditions. The company utilizes what it calls Creative (stem cell-based) technology and other developed proprietary methods in the field of regenerative medicine that would enable drug discovery and life-changing therapies. More information can be found at

Health Point Inc. is committed to deliver safe, effective and affordable stem cell therapies in a bench-to-bed approach, by nurturing cutting-edge research and clinical applications and by matching customer satisfaction in attaining the rejuvenating hope. Health Point Inc. strives to maintain scientific and ethical practices through a Quality Management System in accordance with accepted national and international norms. Health Point Inc. will accomplish this through dedicated efforts of its team to continually monitor and improve the effectiveness of the Quality Management System to excel and innovate thereby reflecting that we are truly pro-Life.

The information contained in this release is provided on an errors and omissions excepted basis. No statements contained within are to be construed as an offer for sale of share capital or any other offer contrary to securities law. Information is current at time of publishing. Health Point Inc. cannot be held responsible for out of date or changing information. It is the responsibility of the reader to seek out up to date company information at and other sources before making any material decisions.
-- EOF ---
Contact Email :
Issued By : Reginald Anderson
Phone : 85281930750
Business Address : 15/F Millennium City 5 (APM)
418 Kwun Tong Rd Central, Hong kong
Country : China
Categories : Business
Tags : health, Stem, Cells, Research, Manufacture, Supply, Investment
Last Updated : Nov 21, 2014

New Press News

blog comments powered by Disqus
Popular TagsMore